Race Oncology Ltd (RAC) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.00x

Race Oncology Ltd (RAC) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting AU$4.00 (capex AU$4.00 ) from operating cash flow of AU$570.64K. See RAC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

AU$4.00
Capex + Investments

Operating Cash Flow

AU$570.64K
AUD

Capital Expenditures

AU$4.00
AUD

Race Oncology Ltd Cash Flow Reinvestment Rate (2011–2013)

Historical reinvestment intensity for Race Oncology Ltd across 3 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Race Oncology Ltd.

Annual Cash Flow Reinvestment Rate for Race Oncology Ltd (2011–2013)

Year-by-year capital reinvestment analysis for Race Oncology Ltd. See Race Oncology Ltd (RAC) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (AUD) Operating CF Capex YoY Change
2013 1.20x AU$4.44 Million AU$3.71 Million AU$31.00K ▼ -77.5%
2012 5.33x AU$35.61 Million AU$6.68 Million AU$218.00K ▲ +414.5%
2011 1.04x AU$12.34 Million AU$11.92 Million AU$72.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow